van de Vijver MJ - Search Results

1

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.

de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Among authors: van de vijver mj. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

2

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al. Schuuring E, et al. Among authors: van de vijver mj, van tinteren h. Cancer Res. 1992 Oct 1;52(19):5229-34. Cancer Res. 1992. PMID: 1394126

3

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Beerman H, Bonsing BA, van de Vijver MJ, Hermans J, Kluin PM, Caspers RJ, van de Velde CJ, Cornelisse CJ. Beerman H, et al. Among authors: van de vijver mj, van de velde cj. Br J Cancer. 1991 Jul;64(1):139-43. doi: 10.1038/bjc.1991.257. Br J Cancer. 1991. PMID: 1854613 Free PMC article. Clinical Trial.

4

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.

van de Vijver M, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R. van de Vijver M, et al. Mol Cell Biol. 1987 May;7(5):2019-23. doi: 10.1128/mcb.7.5.2019-2023.1987. Mol Cell Biol. 1987. PMID: 3299059 Free PMC article.

5

Recent developments in the molecular genetic understanding of breast cancer.

Devilee P, Schuuring E, van de Vijver MJ, Cornelisse CJ. Devilee P, et al. Among authors: van de vijver mj. Crit Rev Oncog. 1994;5(2-3):247-70. doi: 10.1615/critrevoncog.v5.i2-3.70. Crit Rev Oncog. 1994. PMID: 7849087 Review.

6

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cornelis RS, et al. Among authors: van de vijver mj, van vliet m. Cancer Res. 1994 Aug 1;54(15):4200-6. Cancer Res. 1994. PMID: 8033152

7

Molecular genetic changes in human breast cancer.

van de Vijver MJ. van de Vijver MJ. Adv Cancer Res. 1993;61:25-56. doi: 10.1016/s0065-230x(08)60954-9. Adv Cancer Res. 1993. PMID: 8346719 Review. No abstract available.

8

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.

9

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ. van Slooten HJ, et al. Among authors: van dierendonck jh, van de vijver mj, van de velde cj. Br J Cancer. 1996 Jul;74(1):78-85. doi: 10.1038/bjc.1996.319. Br J Cancer. 1996. PMID: 8679463 Free PMC article. Clinical Trial.

10

Three germline mutations in the TP53 gene.

Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ. Cornelis RS, et al. Among authors: van de vijver mj, van vliet m. Hum Mutat. 1997;9(2):157-63. doi: 10.1002/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6. Hum Mutat. 1997. PMID: 9067756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page